Literature DB >> 7285360

A sensitive new method for measurement of guanase with 8-azaguanine in bicine bis-hydroxy ethyl glycine buffer as substrate.

S Ito, T Takaoka, H Mori, A Teruo.   

Abstract

Serum guanase activity has been considered as a possible specific indicator of hepatocellular diseases. However, no suitable method is available for routine clinical determination of serum guanase activity. Conventional assay methods are troublesome and inaccurate, since guanine and 8-azaguanine, the substrates of the enzyme, are scarcely soluble in water so that it is not possible to prepare a stable substrate solution of sufficient concentration for use in assays. A new method was developed for assay of guanase activity by direct colorimetric determination of ammonia. In this method, bicine bis-hydroxy ethyl glycine (dotite bicine) buffer is used for preparation of a stable substrate solution and with a fixed concentration of substrate of sufficient strength serum guanase can be measured sensitively and reproducibly. This assay system could be used as a routine clinical laboratory test in the diagnosis of liver damage.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7285360     DOI: 10.1016/0009-8981(81)90069-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Spectroscopic investigations and hydrogen bond interactions of 8-aza analogues of xanthine, theophylline and caffeine: a theoretical study.

Authors:  Mylsamy Karthika; Ramasamy Kanakaraju; Lakshmipathi Senthilkumar
Journal:  J Mol Model       Date:  2013-01-15       Impact factor: 1.810

2.  Prevention of posttransfusional non-A, non-B hepatitis using the screening test for guanase activity of donor blood.

Authors:  S Ito; Y Tsuji
Journal:  Gastroenterol Jpn       Date:  1988-04

3.  Histochemical demonstration of guanase in human liver with guanine in bicine buffer as substrate.

Authors:  S Ito; Y Xu; A J Keyser; R L Peters
Journal:  Histochem J       Date:  1984-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.